Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Dabrafenib plus trametinib bij BRAF-V600E-gemuteerde zeldzame tumoren
jun 2023 | Hoofd-halsoncologie, Leukemie, Maag-darm-leveroncologie, MM, Neuro-oncologie